Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,527 | 90,909 | 111,810 | 132,172 | 155,796 |
| Receivables | 8,459 | 6,153 | 5,236 | N/A | 5,101 |
| Inventories | 18,085 | 12,592 | 12,681 | 24,313 | 39,671 |
| Other current assets | 8,636 | 9,653 | 3,170 | 3,469 | 2,152 |
| TOTAL | $175,707 | $119,307 | $132,897 | $159,954 | $202,720 |
| Non-Current Assets | |||||
| PPE Net | 4,172 | 3,982 | 4,211 | 4,439 | 4,755 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 1,102 | 1,199 | 1,111 | 1,024 | 1,024 |
| TOTAL | $8,482 | $8,389 | $8,530 | $8,671 | $8,987 |
| Total Assets | $184,189 | $127,696 | $141,427 | $168,625 | $211,707 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,146 | 21,756 | 21,190 | 13,115 | 14,713 |
| Accrued Expenses | N/A | N/A | N/A | 4,923 | 5,075 |
| Other current liabilities | 375 | 368 | 361 | 244 | 259 |
| TOTAL | $30,521 | $22,124 | $21,551 | $18,282 | $23,405 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 3,358 |
| Other Non-Current Liabilities | 127,110 | 127,207 | 127,302 | 127,504 | 127,618 |
| TOTAL | $128,019 | $128,097 | $128,172 | $128,354 | $128,448 |
| Total Liabilities | $158,540 | $150,221 | $149,723 | $146,636 | $151,853 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,750 | 108,467 | 107,668 | 105,960 | 105,895 |
| Common Shares | 119 | 108 | 106 | 106 | 106 |
| Retained earnings | -944,611 | -858,114 | -835,098 | -801,314 | -759,618 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $25,649 | $-22,525 | $-8,296 | $21,989 | $59,854 |
| Total Liabilities And Equity | $184,189 | $127,696 | $141,427 | $168,625 | $211,707 |